Skip to main content
. 2020 Mar 5;124(5):535–543. doi: 10.1016/j.bja.2020.02.003

Table 1.

Patient characteristics. Data presented as patients who had early elevated troponin-T within the first 24 h after surgery vs patients in whom troponin-T remained <99th centile. Data are shown as absolute median (IQR) values or n (%). Odds ratio (OR) with 95% confidence intervals (CIs) shown, where applicable. COPD, chronic obstructive pulmonary disease; IQR, inter-quartile range; RCRI, Revised Cardiac Risk Index.

Troponin, ≥15 ng L−1 Troponin, <15 ng L−1 OR (95% CI)
Age (y) 69 (59–78) 64 (55–72)
BMI (kg m−2) 28.0 (6.1) 28.9 (6.5)
Female sex, n (%) 331 (33.4) 1621 (48.5) 0.69 (0.63–0.76)
RCRI ≥2, n (%) 238 (24.0) 296 (8.9) 2.71(2.32–3.17)
ASA ≥3, n (%) 546 (55.0) 821 (24.6) 3.76 (3.24–4.36)
Coronary artery disease, n (%) 234 (23.6) 293 (8.8) 2.69 (2.30–3.15)
Cardiac failure, n (%) 29 (2.9) 29 (0.9) 3.37 (2.02–5.61)
Diabetes mellitus, insulin treated, n (%) 70 (7.1) 105 (3.1) 2.25 (1.67–3.02)
Diabetes mellitus, tablet treated, n (%) 149 (15.0) 333 (10.0) 1.51 (1.26–1.81)
Cirrhosis, n (%) 8 (0.8) 18 (0.5) 1.50 (0.65–3.43)
Stroke/transient ischaemic attack, n (%) 86 (8.7) 169 (5.1) 1.72 (1.34–2.20)
Asthma, n (%) 83 (8.4) 345 (10.3) 0.81 (0.65–1.02)
COPD, n (%) 111 (11.2) 191 (5.7) 1.96 (1.57–2.45)
Metastases (preop), n (%) 40 (4.0) 120 (3.6) 1.12 (0.79–1.60)
Systolic (mm Hg) 141 (23) 137 (21)
Diastolic (mm Hg) 74 (12) 75 (13)
Heart rate (beats min−1) 76 (14) 76 (13)
Haemoglobin (g L−1) 126 (19) 134 (17)
Intraoperative
Duration of surgery (min) 140 (80–220) 136 (90–205)
Crystalloid (ml kg h−1) 9.4 (6.0–14.3) 9.3 (6.3–13.5)
Fluid including colloid (ml kg h−1) 10.2 (6.5–15.2) 9.9 (6.8–14.3)
Estimated blood loss >500 ml, n (%) 114 (11.5) 279 (8.3)
Blood administered, n (%) 83 (8.3) 123 (3.7)
Postoperative
Planned critical care, n (%) 314 (31.7) 678 (20.3) 1.56 (1.39–1.75)